Miklos Pless

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

Christian Waldherr, Miklos Pless, Helmut R. Maëcke et al. · PubMed · 2002 · 446 citations

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)

Christoph Mamot, Dirk Klingbiel, Felicitas Hitz et al. · Journal of Clinical Oncology · 2015 · 183 citations

Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial

Miklos Pless, Christian Waldherr, Helmut R. Maëcke et al. · Lung Cancer · 2004 · 32 citations

Yttrium-labelled Somatostatin Analogue, Pilot Trial, Radiation Therapy +10

Fatal vascular leak syndrome with extensive hemorrhage, peripheral neuropathy and reactive erythrophagocytosis: an unusual complication of recombinant IL-3 therapy

Nina Hurwitz, A. Probst, Guillaume Zufferey et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1996 · 19 citations

Vascular Disease, Vasculitis, Immunology +23

Synergy of growth factors during mobilization of peripheral blood precursor cells with recombinant human Flt3-ligand and granulocyte colony-stimulating factor in rabbits

Miklos Pless, Aleksandra Wodnar‐Filipowicz, L. John et al. · Experimental Hematology · 1999 · 13 citations

Recombinant Human Flt3-ligand, Stem Cell Mobilization, Immunology +10